Literature DB >> 28885617

Post-translational regulation of p53 function through 20S proteasome-mediated cleavage.

Hilla Solomon1, Bastian Bräuning2,3, Irit Fainer2, Gili Ben-Nissan2, Stav Rabani1, Naomi Goldfinger1, Oren Moscovitz2, Zippora Shakked3, Varda Rotter1, Michal Sharon2.   

Abstract

The tumor suppressor p53 is a transcription factor that regulates the expression of a range of target genes in response to cellular stress. Adding to the complexity of understanding its cellular function is that in addition to the full-length protein, several p53 isoforms are produced in humans, harboring diverse expression patterns and functionalities. One isoform, Δ40p53, which lacks the first transactivation domain including the binding region for the negative regulator MDM2, was shown to be a product of alternative translation initiation. Here we report the discovery of an alternative cellular mechanism for Δ40p53 formation. We show that the 20S proteasome specifically cleaves the full-length protein (FLp53) to generate the Δ40p53 isoform. Moreover, we demonstrate that a dimer of FLp53 interacts with a Δ40p53 dimer, creating a functional hetero-tetramer. Consequently, the co-expression of both isoforms attenuates the transcriptional activity of FLp53 in a dominant negative manner. Finally, we demonstrate that following oxidative stress, at the time when the 20S proteasome becomes the major degradation machinery and FLp53 is activated, the formation of Δ40p53 is enhanced, creating a negative feedback loop that balances FLp53 activation. Overall, our results suggest that Δ40p53 can be generated by a 20S proteasome-mediated post-translational mechanism so as to control p53 function. More generally, the discovery of a specific cleavage function for the 20S proteasome may represent a more general cellular regulatory mechanism to produce proteins with distinct functional properties.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28885617      PMCID: PMC5686354          DOI: 10.1038/cdd.2017.139

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  60 in total

1.  The N terminus of p53 regulates its dissociation from DNA.

Authors:  C Cain; S Miller; J Ahn; C Prives
Journal:  J Biol Chem       Date:  2000-12-22       Impact factor: 5.157

2.  Biochemistry. Structural MS pulls its weight.

Authors:  Michal Sharon
Journal:  Science       Date:  2013-05-31       Impact factor: 47.728

Review 3.  Oxidative stress-mediated regulation of proteasome complexes.

Authors:  Charity T Aiken; Robyn M Kaake; Xiaorong Wang; Lan Huang
Journal:  Mol Cell Proteomics       Date:  2011-05       Impact factor: 5.911

4.  Isolation of a full-length mouse cDNA clone coding for an immunologically distinct p53 molecule.

Authors:  D Wolf; N Harris; N Goldfinger; V Rotter
Journal:  Mol Cell Biol       Date:  1985-01       Impact factor: 4.272

5.  Structure of full-length p53 tumor suppressor probed by chemical cross-linking and mass spectrometry.

Authors:  Christian Arlt; Christian H Ihling; Andrea Sinz
Journal:  Proteomics       Date:  2015-04-21       Impact factor: 3.984

6.  Endoplasmic reticulum stress induces G2 cell-cycle arrest via mRNA translation of the p53 isoform p53/47.

Authors:  Karima Bourougaa; Nadia Naski; Cedric Boularan; Coraline Mlynarczyk; Marco M Candeias; Stefano Marullo; Robin Fåhraeus
Journal:  Mol Cell       Date:  2010-04-09       Impact factor: 17.970

7.  Stress-dependent changes in the properties of p53 complexes by the alternative translation product p53/47.

Authors:  Darren J Powell; Roman Hrstka; Marco Candeias; Karima Bourougaa; Borek Vojtesek; Robin Fåhraeus
Journal:  Cell Cycle       Date:  2008-01-18       Impact factor: 4.534

8.  Proteasomes can degrade a significant proportion of cellular proteins independent of ubiquitination.

Authors:  James M Baugh; Ekaterina G Viktorova; Evgeny V Pilipenko
Journal:  J Mol Biol       Date:  2009-01-08       Impact factor: 5.469

Review 9.  Regulating the 20S proteasome ubiquitin-independent degradation pathway.

Authors:  Gili Ben-Nissan; Michal Sharon
Journal:  Biomolecules       Date:  2014-09-23

10.  Oxidative stress activates a specific p53 transcriptional response that regulates cellular senescence and aging.

Authors:  Valentina Gambino; Giulia De Michele; Oriella Venezia; Pierluigi Migliaccio; Valentina Dall'Olio; Loris Bernard; Simone Paolo Minardi; Maria Agnese Della Fazia; Daniela Bartoli; Giuseppe Servillo; Myriam Alcalay; Lucilla Luzi; Marco Giorgio; Heidi Scrable; Pier Giuseppe Pelicci; Enrica Migliaccio
Journal:  Aging Cell       Date:  2013-03-27       Impact factor: 9.304

View more
  18 in total

1.  Proteolytic dynamics of human 20S thymoproteasome.

Authors:  Ulrike Kuckelkorn; Sabine Stübler; Kathrin Textoris-Taube; Christiane Kilian; Agathe Niewienda; Petra Henklein; Katharina Janek; Michael P H Stumpf; Michele Mishto; Juliane Liepe
Journal:  J Biol Chem       Date:  2019-03-26       Impact factor: 5.157

Review 2.  The role of MDM2-p53 axis dysfunction in the hepatocellular carcinoma transformation.

Authors:  Hui Cao; Xiaosong Chen; Zhijun Wang; Lei Wang; Qiang Xia; Wei Zhang
Journal:  Cell Death Discov       Date:  2020-06-19

3.  Functional regulation of proteins by 20S proteasome proteolytic processing.

Authors:  Maya A Olshina; Gili Ben-Nissan; Michal Sharon
Journal:  Cell Cycle       Date:  2018-02-09       Impact factor: 4.534

Review 4.  Consensus report of the 8 and 9th Weinman Symposia on Gene x Environment Interaction in carcinogenesis: novel opportunities for precision medicine.

Authors:  Michele Carbone; Ivano Amelio; El Bachir Affar; James Brugarolas; Lisa A Cannon-Albright; Lewis C Cantley; Webster K Cavenee; Zhijian Chen; Carlo M Croce; Alan D' Andrea; David Gandara; Carlotta Giorgi; Wei Jia; Qing Lan; Tak Wah Mak; James L Manley; Katsuhiko Mikoshiba; Jose N Onuchic; Harvey I Pass; Paolo Pinton; Carol Prives; Nathaniel Rothman; Said M Sebti; James Turkson; Xifeng Wu; Haining Yang; Herbert Yu; Gerry Melino
Journal:  Cell Death Differ       Date:  2018-10-15       Impact factor: 15.828

Review 5.  p53 Isoforms as Cancer Biomarkers and Therapeutic Targets.

Authors:  Liuqun Zhao; Suparna Sanyal
Journal:  Cancers (Basel)       Date:  2022-06-27       Impact factor: 6.575

6.  Cytoplasmic p53β Isoforms Are Associated with Worse Disease-Free Survival in Breast Cancer.

Authors:  Luiza Steffens Reinhardt; Kira Groen; Brianna C Morten; Jean-Christophe Bourdon; Kelly A Avery-Kiejda
Journal:  Int J Mol Sci       Date:  2022-06-15       Impact factor: 6.208

7.  Conformational stability and dynamics of the cancer-associated isoform Δ133p53β are modulated by p53 peptides and p53-specific DNA.

Authors:  Jiangtao Lei; Ruxi Qi; Yegen Tang; Wenning Wang; Guanghong Wei; Ruth Nussinov; Buyong Ma
Journal:  FASEB J       Date:  2018-12-12       Impact factor: 5.834

Review 8.  The role of MDM2-p53 axis dysfunction in the hepatocellular carcinoma transformation.

Authors:  Hui Cao; Xiaosong Chen; Zhijun Wang; Lei Wang; Qiang Xia; Wei Zhang
Journal:  Cell Death Discov       Date:  2020-06-19

9.  ZNF185 is a p53 target gene following DNA damage.

Authors:  Artem Smirnov; Angela Cappello; Anna Maria Lena; Lucia Anemona; Alessandro Mauriello; Nicola Di Daniele; Margherita Annicchiarico-Petruzzelli; Gerry Melino; Eleonora Candi
Journal:  Aging (Albany NY)       Date:  2018-11-16       Impact factor: 5.682

10.  Cell communication and protein degradation: All in one parasitic package.

Authors:  Michal Sharon; Neta Regev-Rudzki
Journal:  J Extracell Vesicles       Date:  2021-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.